Clinical Trial Update: Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia [Phase 2]

View source ↗

Summary

Phase 2 trial update on convalescent plasma for treating COVID-19 pneumonia; study completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corona Virus Infection
• Pneumonia
• Sars-cov-2

Drugs mentioned

• Convalescent Plasma (convalescent plasma)

Snippet

Sponsor: University of Virginia | Conditions: Corona Virus Infection, SARS-CoV 2 | Phase 2 | Status: COMPLETED | Results posted: 2022-04-01